Jaksch Frank L Jr has filed 5 insider transactions across 1 company since June 2024.
Most recent transaction: a grant/award of 20000 shares of Niagen Bioscience, Inc. ($NAGE) on June 24, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 24, 2025 | Niagen Bioscience, Inc. | $NAGE | Jaksch Frank L Jr | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 78,125,000 | 9999.99% | 0.03% |
| Dec. 13, 2024 | Niagen Bioscience, Inc. | $NAGE | Jaksch Frank L Jr | Director | M | Common Stock | 50001 | $3.66 | 2,356,392.0000 | 77,768,000 | 2.17% | 0.06% |
| Dec. 13, 2024 | Niagen Bioscience, Inc. | $NAGE | Jaksch Frank L Jr | Director | S | Common Stock | 37161 | $6.19 | 2,319,231.0000 | 77,768,000 | 1.58% | 0.05% |
| Dec. 13, 2024 | Niagen Bioscience, Inc. | $NAGE | Jaksch Frank L Jr | Director | M | Employee Stock Options (right to buy) | 50001 | $0.00 | 0.0000 | 77,768,000 | 100.00% | 0.06% |
| June 20, 2024 | Niagen Bioscience, Inc. | $NAGE | Jaksch Frank L Jr | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 74,985,000 | 9999.99% | 0.03% |